Novo Ousts CEO Jorgensen Over Competition, Share Price

finance.yahoo.com/video/novo-ousts-ceo-jorgensen-over-140039655.html

Novo Nordisk is replacing Chief Executive Officer Lars Fruergaard Jorgensen amid increased competition for its Wegovy obesity shots. The move follows a 53% decline in its share price over the past 12 months that has sliced more than $300 billion off its market value. Madison Muller…

This story appeared on finance.yahoo.com, 2025-05-16 14:00:39.
The Entire Business World on a Single Page. Free to Use →